See All Slides - tctmd.com

Slides

Presentation THT 2025

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Presenter: Yogesh Reddy

February 11, 2025

Presentation THT 2025

Impella 5.5: A GameChanger for Cardiogenic Shock

Presenter: Jerome Crowley

February 11, 2025

Presentation THT 2025

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Presenter: John DePietro

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Vectorious: LAP-Guided Patient Self-Management

Presenter: William Abraham

February 11, 2025

Presentation THT 2025

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Presenter: Joseph Ibrahim

February 11, 2025

Presentation THT 2025

Differential Outcome of Hypotension vs. Hypoperfusion in SCAI Stage B Cardiogenic Shock: Insights From Houston Methodist Advanced Heart Failure Registry (HM-AHFR)

Presenter: Sumitabh Singh

February 11, 2025

Presentation THT 2025

New Technologies for Pulsatile ECMO

Presenter: Nader Moazami

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Are Wearables and Smart Devices a More Scalable Solution

Presenter: Akshay Desai

February 11, 2025

Advertisement

Slides

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Impella 5.5: A GameChanger for Cardiogenic Shock

Efficacy of Silverlon Silver Plated Dressing Pad in Reducing Left Ventricular Assist Device Driveline Infections When Compared to Chlorhexidine Impregnated Disc

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Vectorious: LAP-Guided Patient Self-Management

Trends and Outcomes of Revascularization in Cardiogenic Shock: A Matched Cohort Analysis

Differential Outcome of Hypotension vs. Hypoperfusion in SCAI Stage B Cardiogenic Shock: Insights From Houston Methodist Advanced Heart Failure Registry (HM-AHFR)

New Technologies for Pulsatile ECMO

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Are Wearables and Smart Devices a More Scalable Solution

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content